Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=150"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=150

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00458393-c1a51113",
        "title": "TDF/FTC vs Placebo: Diagnosis of Gonorrhea During the Follow-up Period",
        "summary": "18 of 1226 against 30 of 1229; risk difference -1.0 points, 95% interval -2.1 to 0.1; NCT00458393, Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men",
        "record": "/library/comparisons/NCT00458393-c1a51113",
        "nct_id": "NCT00458393",
        "kind": "outcome",
        "participants": 2455,
        "risk_difference": {
          "value": -0.009728197170871955,
          "lower": -0.021277738182726318,
          "upper": 0.0013787387255951057
        },
        "group_1": "18 of 1,226",
        "group_2": "30 of 1,229",
        "difference": "-1.0 points",
        "interval": "-2.1 to 0.1",
        "trial_title": "Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men"
      },
      {
        "id": "NCT00458393-cd1718e3",
        "title": "TDF/FTC vs Placebo: Grade 2, 3, or 4 Laboratory Adverse Events",
        "summary": "70 of 1229 against 79 of 1226; risk difference -0.7 points, 95% interval -2.7 to 1.2; NCT00458393, Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men",
        "record": "/library/comparisons/NCT00458393-cd1718e3",
        "nct_id": "NCT00458393",
        "kind": "outcome",
        "participants": 2455,
        "risk_difference": {
          "value": -0.007480318618699536,
          "lower": -0.026579579117234742,
          "upper": 0.011534995110370382
        },
        "group_1": "70 of 1,229",
        "group_2": "79 of 1,226",
        "difference": "-0.7 points",
        "interval": "-2.7 to 1.2",
        "trial_title": "Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=151",
  "request_id": "gVpvaTOKaBasbWXo"
}